Takeda gets EMA nod for additional subcutaneous administration of Takhzyro in Hereditary Angioedema patients Ruchika Sharma25 Feb 2025 10:30 AM ISTZurich: Takeda has announced that the European Medicines Agency (EMA) has given approval for an additional 2 mL pre-filled pen option for...
Sebetralstat, wonder drug for Hereditary Angioedema Attacks, claims study Dr Manoj Kumar Nayak5 Aug 2024 8:45 PM ISTSebetralstat- a wonder drug for Hereditary Angioedema Attacks Hereditary angioedema (HAE) is a rare disease characterized by recurrent swelling of...
USFDA approves Alembic Pharma Icatibant Injection for acute attacks of hereditary angioedema Ruchika Sharma17 Jun 2024 3:29 PM ISTIcatibant injection is indicated for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.
Donidalorsen Therapy Effective Against Hereditary Angioedema: NEJM Jacinthlyn Sylvia5 Jun 2024 6:30 AM ISTA recent phase published in the New England Journal of Medicine 3 trial demonstrated that donidalorsen, an antisense oligonucleotide, significantly...
Once-daily, oral berotralstat may rapidly and substantially reduce hereditary angioedema attacks: Study Medha Baranwal7 March 2024 6:30 PM ISTUSA: Once-daily, oral berotralstat (Orladeyo) treatment may lead to fast, considerable, and consistent hereditary angioedema (HAE) attack decreases...
Donidalorsen taken every eight weeks is safe and has durable efficacy in reducing attack rates in hereditary angioedema: Study Medha Baranwal6 March 2024 3:00 AM ISTUSA: A previous phase 2 open-label extension (OLE) study of donidalorsen in patients with Type 1/2 hereditary angioedema (HAE) showed a 76% reduction...
Investigational oral drug sebetralstat provided on-demand relief during tissue swelling attacks from hereditary angioedema: Phase 3 study Medha Baranwal29 Feb 2024 9:15 PM ISTUSA: A phase III study showed that an investigational oral drug sebetralstat provided on-demand relief during tissue swelling attacks from hereditary...
Donidalorsen reduces rate of angioedema attacks in patients with hereditary angioedema in phase 3 trial Dr. Kamal Kant Kohli31 Jan 2024 5:15 AM ISTDonidalorsen is an investigational ligand-conjugated antisense (LICA) drug designed to target and reduce the production of prekallikrein (PKK) that...
Garadacimab, XIIa inhibitor, receives FDA and EMA Filing acceptance for hereditary angioedema Medha Baranwal22 Dec 2023 5:45 PM ISTUSA: Garadacimab, a first-in-class factor XIIa inhibitor, has received the Food and Drug Administration (FDA) and European Medicines Agency (EMA)...
Oral Berotralstat as effective as intravenous agents for long-term prophylaxis of hereditary angioedema Niveditha Subramani29 Nov 2023 4:00 PM ISTHereditary angioedema (HAE) is a rare genetic condition that causes swelling under the skin and lining of the gut and lungs. It can happen in...
Lanadelumab may prove effective prophylactic therapy for hereditary angioedema Aditi28 Aug 2023 8:00 PM ISTHide et al., and colleagues recently demonstrated the effectiveness of lanadelumab in preventing attacks of hereditary angioedema (HAE) in Japanese...
Prophylactic monthly Garadacimab safe and effective against hereditary angioedema attacks Dr.Niharika Harsha B4 April 2023 3:00 AM ISTA new trial found that prophylactic subcutaneous administration of garadacimab every month in adults and adolescents was safe and has significantly...
